Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh Morrison

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nephrology News & Issues|June 4, 2016
How to improve living donationJosh Morrison
The American Journal of Bioethics : AJOB|February 22, 2021
What Fairness Demands: How We Can Promote Fair Compensation in Human Infection Challenge Studies and BeyondSeán O'Neill McPartlin, Josh Morrison
Vaccine|December 19, 2021
Considering human challenge trials for tuberculosis vaccine developmentGavriel Kleinwaks, Virginia Schmit, Josh Morrison
Vaccine|May 31, 2022
Corrigendum to "Considering human challenge trials for tuberculosis vaccine development" [Vaccine 40(2) (2022) 173-174]Gavriel Kleinwaks, Virginia Schmit, Josh Morrison
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 4, 2021
Exploring Risks of Human Challenge Trials For COVID-19David Manheim, Witold Wiȩcek, Virginia Schmit, et al.
BMJ (Clinical Research Ed.)|November 10, 2020
Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?Seán O'Neill McPartlin, Josh Morrison, Abie Rohrig, et al.
Journal of Medical Ethics|December 30, 2023
Exploring the ethics of tuberculosis human challenge modelsAbie Rohrig, Josh Morrison, Gavriel Kleinwaks, et al.
Plos One|November 2, 2022
Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trialsAbigail A Marsh, Monica Magalhaes, Matthew Peeler, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2023
Joint statement in support of hepatitis C human challenge studiesHarvey J Alter, Eleanor Barnes, Mia J Biondi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2020
Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine DevelopmentLinh Chi Nguyen, Christopher W Bakerlee, T Greg McKelvey, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nephrology News & Issues|June 4, 2016
How to improve living donationJosh Morrison
The American Journal of Bioethics : AJOB|February 22, 2021
What Fairness Demands: How We Can Promote Fair Compensation in Human Infection Challenge Studies and BeyondSeán O'Neill McPartlin, Josh Morrison
Vaccine|December 19, 2021
Considering human challenge trials for tuberculosis vaccine developmentGavriel Kleinwaks, Virginia Schmit, Josh Morrison
Vaccine|May 31, 2022
Corrigendum to "Considering human challenge trials for tuberculosis vaccine development" [Vaccine 40(2) (2022) 173-174]Gavriel Kleinwaks, Virginia Schmit, Josh Morrison
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 4, 2021
Exploring Risks of Human Challenge Trials For COVID-19David Manheim, Witold Wiȩcek, Virginia Schmit, et al.
BMJ (Clinical Research Ed.)|November 10, 2020
Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?Seán O'Neill McPartlin, Josh Morrison, Abie Rohrig, et al.
Journal of Medical Ethics|December 30, 2023
Exploring the ethics of tuberculosis human challenge modelsAbie Rohrig, Josh Morrison, Gavriel Kleinwaks, et al.
Plos One|November 2, 2022
Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trialsAbigail A Marsh, Monica Magalhaes, Matthew Peeler, et al.
The Lancet. Gastroenterology & Hepatology|September 24, 2023
Joint statement in support of hepatitis C human challenge studiesHarvey J Alter, Eleanor Barnes, Mia J Biondi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2020
Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine DevelopmentLinh Chi Nguyen, Christopher W Bakerlee, T Greg McKelvey, et al.
Pageof 2